Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 760.00
+4.00 (0.53%)
Feb 17, 2026, 9:12 AM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 4.28 billion as of February 13, 2026. Its market cap has increased by 15.67% in one year.
Market Cap
4.28B
Enterprise Value
3.18B
Revenue
1.43B
Ranking
n/a
PE Ratio
21.09
Stock Price
760.00
Market Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 4.28B, a decrease of -61.24%. That is a compound annual growth rate of -7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 4.28B | 14.55% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 15.27T |
| HOYA Corporation | 9.51T |
| Takeda Pharmaceutical Company | 8.87T |
| Otsuka Holdings | 5.59T |
| Modalis Therapeutics | 5.11B |
| Transgenic Group | 4.93B |
| Ribomic | 4.45B |
| teno. Holdings Company | 4.12B |